ZAVICEFTA 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

( ARTG ) Zavicefta is indicated for the treatment of the following infections in adults (see sections 4.4 Special warnings and precautions for use and 5.1 Pharmacodynamic properties):, Complicated intra-abdominal infection (cIAI) in combination with metronidazole. Complicated urinary tract infection (cUTI) including pyelonephritis., Hospital-acquired pneumonia (HAP) including ventilator associated pneumonia (VAP).,Zavicefta is indicated for the treatment of the following infections in infants and paediatric patients (greater than or equal to 3 months to < 18 years) (see sections 4.4 Special warnings and precautions for use and 5.1 Pharmacodynamic properties):, Complicated intra-abdominal infection (cIAI) in combination with metronidazole. Complicated urinary tract infection (cUTI) including pyelonephritis.,Consideration should be given to official guidance on the appropriate use of antibacterial agents.,To reduce the development of drug-resistant bacteria and maintain the effectiveness of Zavicefta and other antibiotics, Zavicefta should be used in combination with an antibacterial agent(s) active against Gram-positive and/or anaerobic pathogens when these are known or suspected to be contributing to the infectious process.